293 related articles for article (PubMed ID: 26363010)
1. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
[TBL] [Abstract][Full Text] [Related]
2. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
[TBL] [Abstract][Full Text] [Related]
3. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration.
Galvagni F; Nardi F; Maida M; Bernardini G; Vannuccini S; Petraglia F; Santucci A; Orlandini M
Oncotarget; 2016 Mar; 7(9):10090-103. PubMed ID: 26848865
[TBL] [Abstract][Full Text] [Related]
4. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
[TBL] [Abstract][Full Text] [Related]
5. CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells.
Barbera S; Raucci L; Lugano R; Tosi GM; Dimberg A; Santucci A; Galvagni F; Orlandini M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830297
[TBL] [Abstract][Full Text] [Related]
6. CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin.
Lugano R; Vemuri K; Barbera S; Orlandini M; Dejana E; Claesson-Welsh L; Dimberg A
FASEB J; 2023 Apr; 37(4):e22894. PubMed ID: 36961390
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.
Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M
Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
Bao L; Tang M; Zhang Q; You B; Shan Y; Shi S; Li L; Hu S; You Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):467-474. PubMed ID: 27255994
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
11. The epidermal growth factor-like domain of CD93 is a potent angiogenic factor.
Kao YC; Jiang SJ; Pan WA; Wang KC; Chen PK; Wei HJ; Chen WS; Chang BI; Shi GY; Wu HL
PLoS One; 2012; 7(12):e51647. PubMed ID: 23272129
[TBL] [Abstract][Full Text] [Related]
12. The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration.
Barbera S; Nardi F; Elia I; Realini G; Lugano R; Santucci A; Tosi GM; Dimberg A; Galvagni F; Orlandini M
Cell Commun Signal; 2019 May; 17(1):55. PubMed ID: 31138217
[TBL] [Abstract][Full Text] [Related]
13. DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation.
Liu Y; Zhang L; Liu Y; Sun C; Zhang H; Miao G; Di CX; Zhou X; Zhou R; Wang Z
J Cell Physiol; 2015 May; 230(5):1094-103. PubMed ID: 25294801
[TBL] [Abstract][Full Text] [Related]
14. Tumor vessel biology in pediatric intracranial ependymoma.
Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
[TBL] [Abstract][Full Text] [Related]
15. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
16. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of αII-spectrin affects endothelial cell-matrix contact and migration leading to impairment of angiogenesis in vitro.
Machnicka B; Ponceau A; Picot J; Colin Y; Lecomte MC
Cell Mol Biol Lett; 2020; 25():3. PubMed ID: 32042281
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization.
Dieterich LC; Mellberg S; Langenkamp E; Zhang L; Zieba A; Salomäki H; Teichert M; Huang H; Edqvist PH; Kraus T; Augustin HG; Olofsson T; Larsson E; Söderberg O; Molema G; Pontén F; Georgii-Hemming P; Alafuzoff I; Dimberg A
J Pathol; 2012 Nov; 228(3):378-90. PubMed ID: 22786655
[TBL] [Abstract][Full Text] [Related]
19. C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.
Khan KA; McMurray JL; Mohammed F; Bicknell R
FEBS J; 2019 Sep; 286(17):3299-3332. PubMed ID: 31287944
[TBL] [Abstract][Full Text] [Related]
20. The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target.
Orlandini M; Galvagni F; Bardelli M; Rocchigiani M; Lentucci C; Anselmi F; Zippo A; Bini L; Oliviero S
Oncotarget; 2014 May; 5(9):2750-60. PubMed ID: 24809468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
